(Q79847215)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

Erb-b2 receptor tyrosine kinase 2

26 December 2019

main subject

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Henry Leonidas Gómez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Yun Gong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kai Yan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Feng Lin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Keith Anderson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Christos Sotiriou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Frankie A Holmes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Vicente Valero

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Daniel Booser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

John E Pippen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Svetislava Vukelja

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jaime Mejia

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Luis J Barajas

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kenneth R Hess

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Nour Sneige

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Gabriel N Hortobagyi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Lajos Pusztai

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

W Fraser Symmans

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

203-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Interlaboratory variation in results from immunohistochemical assessment of estrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Gene-Expression Profiles in Hereditary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Evaluation of DNA microarray results with quantitative gene expression platforms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immunocytochemical assay, and northern blot: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

A concordance correlation coefficient to evaluate reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Evaluation of gene expression measurements from commercial microarray platforms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Impact of microarray data quality on genomic data submissions to the FDA.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Quality assurance in immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970042-6

7 January 2021

10.1016/S1470-2045(07)70042-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17329190%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference